Ajovy is a prescription drug that is used to prevent migraine headaches. It was approved by the U.S. Food and Drug Administration (FDA) in 2018 and is now widely used by people suffering from chronic migraine. While Ajovy has proven to be an effective treatment for some patients, it is important to understand the potential side effects associated with the drug in order to ensure its safe and effective use. This article will explore the potential side effects of Ajovy and how they can be managed.
Ajovy is a medication that is used to prevent migraine headaches. It is a monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) receptors on the surface of nerve cells in the brain. By blocking the action of CGRP, Ajovy is able to reduce the frequency and intensity of migraine headaches. Ajovy is administered as an injection once every four weeks and is available in both an auto-injector and a prefilled syringe.
Like all medications, Ajovy can cause side effects. The most common side effects of Ajovy are injection site reactions, such as redness, itching, pain, swelling, and irritation. Other common side effects include nausea, fatigue, and upper respiratory tract infections. In rare cases, Ajovy can cause serious side effects. These include anaphylaxis, a severe allergic reaction that can cause difficulty breathing, hives, and swelling of the face, lips, tongue, and throat. It is important to seek medical attention immediately if any of these symptoms occur. Ajovy can also cause liver damage, which can lead to jaundice, dark urine, and abdominal pain. It is important to speak to a doctor if any of these symptoms occur. Additionally, Ajovy can cause an increase in blood pressure, which can lead to dizziness, headaches, and blurred vision.
The side effects of Ajovy can be managed with proper monitoring and treatment. It is important to speak to a doctor if any side effects occur, as they may be able to adjust the dosage or switch to a different medication. Additionally, it is important to monitor for any changes in blood pressure, as this can be an indication of an increase in blood pressure. It is also important to stay hydrated and get plenty of rest. Additionally, it is important to avoid alcohol and other substances that can increase the risk of side effects.
Ajovy is an effective medication for preventing migraine headaches, but it is important to understand the potential side effects associated with the drug. Common side effects include injection site reactions, nausea, fatigue, and upper respiratory tract infections. In rare cases, Ajovy can cause serious side effects, such as anaphylaxis, liver damage, and increased blood pressure. It is important to speak to a doctor if any side effects occur, as they may be able to adjust the dosage or switch to a different medication. Additionally, it is important to stay hydrated and get plenty of rest, as well as avoid alcohol and other substances that can increase the risk of side effects.
1.
Charles III, King of Kings, is Cancerous.
2.
Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.
3.
Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival
4.
Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.
5.
WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research
1.
The benefits and risks of taking fludrocortisone for adrenal insufficiency
2.
Ultimate Guide to Oncology Services in the USA
3.
Unveiling New Hope: Potential Therapeutic Targets in Hematological Malignancies
4.
Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools
5.
Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Oropharyngeal Cancer in Relation to HPV Status
2.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
3.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation